Potential new target for Alzheimer's disease
Date published:
Tuesday, March 3, 2009News source:
Alzheimer's SocietyRegion:
United Kingdom Featured item on home page:
no
Dementia is a terminal condition that causes a gradual loss of brain function. There are over 100 types of dementia, of which Alzheimer’s is the most common.
Each caused by different diseases of the brain. Prion diseases are a rare group of dementias, such as CJD and BSE, in which prion proteins clump together in the brain.
Changes in the protein called amyloid occur in the brains of people with both Prion dementias and Alzheimer's disease. However, these are distinctly different conditions and people with Prion dementias do not develop the same brain changes of Alzheimer's disease.
Director of Research
Alzheimer's Society
Changes in the protein called amyloid occur in the brains of people with both Prion dementias and Alzheimer's disease. However, these are distinctly different conditions and people with Prion dementias do not develop the same brain changes of Alzheimer's disease.
'This interesting study found the part of a prion protein that cause clusters of amyloid to form in the brain. More research is now needed to see if prion proteins could be a new target for Alzheimer's or if they only play a part in prion dementias.Prof Clive Ballard
One million people will develop dementia in the next 10 years. We must act now and start investing in dementia research to find effective treatments for this devastating disease.'
Director of Research
Alzheimer's Society
Similar entries
- 'Harmless' prion protein linked to Alzheimer's disease
- Prions complicit in Alzheimer’s disease
- New protein target in fight against Alzheimer's
- Alzheimer's Society comment: Sleep deprivation and dementia
- Alzheimer's Society comment on research that genes in early onset are associated with memory
- Discovery allows scientists to block Alzheimer's
- Alzheimer's Society comments on new research
- Alzheimer's Society comment on benefits of weekly curry
- Alzheimer's Society comment: New Alzheimer's drug research
- Research adds weight to new thinking on Alzheimer's disease: Alzheimer's Society UK





